Navigation Links
UBC professor wins Canada's top pharmaceutical research award
Date:11/19/2012

UBC microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honour in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unravelling the complex interactions between antibiotics and bacteria.

"The Prix Galien is a testament to Bob Hancock's profound impact on Canadian health research," said Simon Peacock, Dean of UBC's Faculty of Science. "His research focuses on the growing challenge of antibiotic resistance and has resulted in new therapeutic approaches to infectious diseases, like malaria."

Hancock is a leader in Canadian health research, focusing on the prevention and treatment of infectious disease. At UBC he established the Centre for Microbial Diseases and Immunity Research (CMDR) and also co-founded the Centre for Drug Research and Development (CDRD), a national not-for-profit drug development and commercialization centre.

Hancock's research interests include antibiotic uptake and resistance, cationic peptides as novel antimicrobials, innate immunity, and bacterial genomics. His breakthrough discovery of a novel way of selectively modulating immunity and suppressing harmful inflammation while retaining protective immunity has, according to Prix Galien Canada, the potential to revolutionize human healthcare.


'/>"/>

Contact: Silvia Moreno-Garcia
silvia.moreno-garcia@science.ubc.ca
604-822-5001
University of British Columbia
Source:Eurekalert

Page: 1

Related medicine news :

1. Guys, take note: Male birth control pill may be ready soon, says Texas A&M professor
2. IHME professor named first health measurement winner of prestigious innovation award
3. From textbook to flexbook: Professor uses new collaborative tool in the classroom
4. President Obama names SF State math professor a top young scientist
5. Women professorships low in some Scandinavian universities due to sexism
6. Louisiana Tech biomedical engineering professor earns recognition, funding for research
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. Louisiana Tech University professor earns NSF Early Career Development grant
9. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Children ... bodies, a researcher at the Icahn School of Medicine at Mount Sinai has ... found that when young children are exposed to secondhand marijuana smoke, measurable amounts ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... up with a schizophrenic mother in a unique, personal perspective through animation. ... treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, ...
(Date:12/7/2016)... ... 2016 , ... It is vital for any lab to secure funding, and ... team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline ... operate in a GLP (Good Laboratory Practice) fashion. , With features designed to simplify ...
(Date:12/7/2016)... ... 07, 2016 , ... Levels of a protein in the blood associated with ... online in the journal Radiology. , Heart disease and brain disease exact a major ... rapidly aging population. Damage to both organs often occurs at a subclinical stage, or ...
(Date:12/7/2016)... ... December 07, 2016 , ... ODU, a worldwide leader ... market its advanced highly customizable contact technology solutions. , ODU Single Contact Technology ... are ideal for a wide range of applications that require customization from industries ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , December 7, 2016 ... Market Research titled , Global Market Study on Multiplex Detection ... 2024 , the global multiplex detection immunoassay market is expected ... period 2016-2024. ... , , ...
(Date:12/7/2016)... , December 7, 2016 ... reach a value of USD 3.9 billion by ... View Research, Inc. The growth of the market ... and continuous technological advancements by the market players. ... due to increasing donation, rising awareness about transfusion-transmitted ...
(Date:12/6/2016)... , Dec. 6, 2016  Alopexx Oncology, LLC ... a recombinant antibody fusion protein (immunocytokine) composed of interleukin-2 ... the same target on B cells as Rituxan and ... components but is also involved in tumor targeting, engagement ... vaccine effect. The results of the study (abstract #95954) ...
Breaking Medicine Technology: